Joel Goldberg sits down with Dr. Shane Schaffer, co-founder and CEO of Cingulate Therapeutics, the biopharma company on a mission to become the next-gen pharma powerhouse…right from Kansas City. It may be the 25-year industry vets biggest project yet, but thanks to a breakthrough drug delivery platform, is an accomplishment that also seems inevitable. New products mean new standards, and they’re being set higher than ever, putting life-changing relief on the horizon for millions who suffer from ADHD and anxiety, while optimizing results.

For Extra Innings visit: https://youtu.be/hG4w_htUl5k

Website: https://www.cingulate.com
Twitter: https://twitter.com/shanejschaf | https://twitter.com/CingulateInc
Facebook: https://www.facebook.com/CingulateTherapeutics/